YouTube video by PrecisionLife

Watch Steve Gardner interview Action for ME CEO Sonya Chowdhury for the Biology Matters podcast on ME/CFS, long COVID, breakthroughs and reasons for hope.

Watch Krystyna Taylor present PrecisionLife’s validation of genetic risk factors for endometriosis using combinatorial analysis.

PrecisionLife and Ovation identify genetic biomarkers to predict GLP-1 response and expand their partnership to develop precision prescribing tools.

YouTube video by Action For ME

Groundbreaking ME study identifies 250+ genes, links with long COVID, and uncovers new drug repurposing opportunities to advance targeted treatments

Background: Myalgic encephalomyelitis (also known as ME/CFS or simply ME) has severely impacted the lives of tens of millions of people globally, but the disease currently has no accurate diagnostic t...

Background: Myalgic encephalomyelitis (also known as ME/CFS or simply ME) has severely impacted the lives of tens of millions of people globally, but the disease currently has no accurate diagnostic t...

PrecisionLife and Ovation partner to develop real-world GLP-1 drug-response biomarkers to support value-based reimbursement and improve patient outcomes.

Even a basic definition of endometriosis tells us a lot about why we need to rethink how we’re dealing with this condition. Rowan Gardner is co-founder of...

Background Endometriosis affects about 10% of women usually of reproductive age. It often has severe negative impacts on patients’ quality of life, but the average time to a definitive diagnosis remai...